STIM — Neuronetics Cashflow Statement
0.000.00%
Last trade - 00:00- $115.17m
- $156.70m
- $149.16m
Annual cashflow statement for Neuronetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -31.2 | -37.2 | -30.2 | -43.7 | -39.1 |
| Depreciation | |||||
| Non-Cash Items | 8.79 | 9.55 | 10.2 | 17.5 | 8.72 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.64 | -4.78 | -14.1 | -6.81 | 6.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -28 | -30.7 | -32 | -31 | -20.4 |
| Capital Expenditures | -2.35 | -3.27 | -2.37 | -1.47 | -0.801 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -7.49 | 10 | 1.05 | -0.947 | — |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9.84 | 6.73 | -1.32 | -2.41 | -0.801 |
| Financing Cash Flow Items | -0.401 | -0.091 | -1.1 | -6.81 | -2.96 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 83 | 0.207 | 22.7 | -6.81 | 35.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 45.2 | -23.8 | -10.7 | -40.2 | 14.7 |